Shilpa Medicare Limited (NSE:SHILPAMED)
India · Delayed Price · Currency is INR 388.90
+14.20 (3.79%)
Apr 2, 2026, 3:30 PM IST
Shilpa Medicare Market Cap
Shilpa Medicare has a market cap or net worth of 76.03 billion as of April 2, 2026. Its market cap has increased by 32.67% in one year.
Market Cap
76.03B
Enterprise Value
81.76B
Revenue
14.33B
Ranking
n/a
PE Ratio
50.67
Stock Price
388.90
Market Cap Chart
Since July 19, 1999, Shilpa Medicare's market cap has increased from 45.10M to 76.03B, an increase of 168,496.00%. That is a compound annual growth rate of 32.05%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Apr 2, 2026 | 76.03B | 21.03% |
| Dec 31, 2025 | 62.82B | -11.35% |
| Dec 31, 2024 | 70.86B | 147.08% |
| Dec 29, 2023 | 28.68B | 18.74% |
| Dec 30, 2022 | 24.15B | -48.10% |
| Dec 31, 2021 | 46.54B | 26.78% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| NATCO Pharma | 179.45B |
| Alembic Pharmaceuticals | 133.08B |
| Alivus Life Sciences | 120.80B |
| Cohance Lifesciences | 119.34B |
| Strides Pharma Science | 88.82B |
| Akums Drugs and Pharmaceuticals | 76.01B |
| Sudeep Pharma | 69.35B |
| Aarti Pharmalabs | 57.57B |